Source: NITI Aayog
Context
NITI Aayog released the report “Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035”, proposing major policy reforms, a ₹50,000-crore BioEconomy Growth Fund, and six National BioMissions to make India one of the top three biotechnology nations by 2035.
What is the Bioeconomy?
The bioeconomy refers to economic activities based on the use of biological resources, biotechnology, and life sciences to produce products and services in sectors such as healthcare, agriculture, food, energy, and the environment.
Vision
- Make India one of the Top 3 biotechnology powers by 2035.
- Build globally competitive biotechnology companies.
- Promote innovation, biomanufacturing, and employment.
Major Recommendations
| Aspect | Details |
|---|---|
| Recommendation | Establish a ₹50,000-crore BioEconomy Growth Fund for 2026–2035. |
| Primary Objective | Support biotechnology startups and industries by accelerating commercialization of innovations. |
| Key Purpose | Bridge the “Valley of Death”—the gap between laboratory research and commercial production. |
| Financial Support Mechanisms | Blended finance, Equity-risk funding, Viability Gap Funding (VGF), and Infrastructure support. |
| Priority Sectors | Biomanufacturing, Advanced therapeutics, Synthetic biology, Fermentation technologies, and Diagnostics. |
Six National BioMissions
| National BioMission | Focus Area |
|---|---|
| 1. GeneIndia | Affordable gene therapy and cell therapy for improved healthcare. |
| 2. AgriBio 2.0 | Develop climate-resilient gene-edited crops and promote biological inputs for sustainable agriculture. |
| 3. BioX Foundry | Commercialisation of synthetic biology innovations. |
| 4. One Health Grid | Integrated surveillance of infectious diseases and Antimicrobial Resistance (AMR). |
| 5. Marine Biotechnology Mission | Promote seaweed cultivation and development of marine bio-products. |
| 6. BioPharmaNext | Promote biologics, biosimilars, and AI-enabled drug discovery. |
